Or program the T-cells to attack mesenchymal cells that are producing the defective ones. I'd wager that the process would still be much more difficult than tar

Or program the T-cells to attack mesenchymal cells that are producing the defective ones. I'd wager that the process would still be much more difficult than targeting cancerous cells, and certainly be very complicated. But, there's hope for other diseases, though the article is focused on cancer: > Not only can this technology help revolutionize TCR-T cell therapies for cancer, but it will also be a powerful tool for discovering other immunological agents, including antibodies and CAR-T cells, and for elucidating new immunology and cancer biology at a depth not possible before.